ACTG A5241: The Optimized Treatment that Includes or Omits NRTIs (OPTIONS) Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Agency: NIH/NIN/Washington University
Agency Award Number: U01NS032228
A subcontract to Washington University to maintain an effective collaborative clinical study group dedicated to the study of HIV-associated neurologic disease.